Loading live market data…

Crescent Biopharma, Inc.

NASDAQ:CBIO

$15.305 USD

-$0.39 (-2.45%)

Volume
77.93K
Average Volume
319.62K
Market Capitalization
$421.99M
P/E Ratio
-1.40
Dividend Yield
0.00%
Price Target
$35.00
Year High
$27.41
Year Low
$8.72
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$13.78

CBIO Estimated and Actual Revenue by Quarter

CBIO Estimated and Actual EPS by Quarter

CBIO Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 3 -75589 -75589 -75589 -75589 -75589 -75589
2027-09-30 3 -102.18K -102.18K -102.18K -102.18K -102.18K -102.18K
2027-06-30 3 -138.12K -138.12K -138.12K -138.12K -138.12K -138.12K
2027-03-31 4 -186.71K -186.71K -186.71K -186.71K -186.71K -186.71K
2026-12-31 4 -214.28K -214.28K -214.28K -214.28K -214.28K -214.28K
2026-09-30 7 -214.29K -214.28K -214.28K -214.29K -214.28K -214.28K
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 3 -30.8M -30.8M -30.8M 55.28M 55.28M 55.28M
2027-09-30 3 -30.4M -30.4M -30.4M 74.72M 74.72M 74.72M
2027-06-30 3 -26.04M -26.04M -26.04M 101.01M 101.01M 101.01M
2027-03-31 4 -24.42M -24.42M -24.42M 136.54M 136.54M 136.54M
2026-12-31 4 -26.6M -26.6M -26.6M 156.71M 156.71M 156.71M
2026-09-30 7 -26.26M -23.15M -24.88M 156.71M 156.71M 156.71M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 3 125.98K 125.98K 125.98K 1 -1.01333 -1.01333 -1.01333
2027-09-30 3 170.3K 170.3K 170.3K 1 -1 -1 -1
2027-06-30 3 230.2K 230.2K 230.2K 1 -0.85667 -0.85667 -0.85667
2027-03-31 4 311.18K 311.18K 311.18K 1 -0.80333 -0.80333 -0.80333
2026-12-31 4 357.14K 357.14K 357.14K 1 -0.87516 -0.87516 -0.87516
2026-09-30 7 357.14K 357.14K 357.14K 3 -0.86387 -0.76157 -0.8184